Biochemical and clinical aspects of advanced oxidation protein products in kidney diseases and metabolic disturbances

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue

Abstract

Intensified oxidative modification of proteins and increased concentration of advanced oxidation protein products (AOPPs) are confirmed by many experimental investigations in different pathological states, especially these with well-known participation of oxidative stress (OS) in etiopathogenesis but also these with not well recognized its role. Presented data indicate that AOPPs play a significant role in many disorders with chronic background, because of they reflect both intensification of OS and the degree of pathological changes connected with OS in these diseases. This review sets out the clinical and diagnostic aspects of AOPPs in these diseases such as: renal diseases with different etiology, cardiovascular diseases, as well as connected with metabolic disturbances – e.g. diabetes, atherosclerosis or metabolic syndrome. Moreover results of investigation about utility of AOPPs measurement, mainly in plasma/serum, in these diseases are presented. The review and evaluation of application of AOPPs as useful marker in diagnosis, prognosis and monitoring the course of these diseases were performed. This paper also describes the suggested mechanisms of their action which contribute to biochemical and clinic changes undergoing in the condition of increased OS. Diagnostic or prognostic utility of AOPPs are especially indicated in the course of diabetes and its complications (diabetic nephropahy) and cardiovascular diseases.

Authors and Affiliations

Agnieszka Piwowar

Keywords

Related Articles

Metabolic and nutritional aspects of cancer

Cancer, being in fact a generalized disease involving the whole organism, is most frequently associated with metabolic deregulation, a latent inflammatory state and anorexia of various degrees. The pathogenesis of this d...

Znaczenie czynnika H w patogenezie zakażenia krętkami Borrelia

Czynnik H (CFH) – to jeden z istotnych regulatorów alternatywnej drogi układu dopełniacza. Jest glikoproteiną należącą do rodziny białek H, syntetyzowaną przede wszystkim w wątrobie i składaną w surowicy w globularne bi...

Limfocele – powikłanie urologiczne po przeszczepie nerki

Przeszczep nerki jest najlepszą metodą leczenia nerkozastępczego, zapewniającą pacjentomdłuższe przeżycia i lepszą jakość życia. Na wynik leczenia przeszczepianiem nerki wpływa występowanie powikłań, w tym urologicznych....

AMP-activated protein kinase (AMPK) as therapeutic target

AMP-activated protein kinase (AMPK) is one of the major energy sensor at both: cellular and whole body level. It exists as heterotrimer containing three subunits: the catalytic α subunit, β and regulatory γ. AMPK is loca...

Hypothermia – mechanism of action and pathophysiological changes in the human body

This review focuses on the physiological responses and pathophysiological changes induced by hypothermia. Normal body function depends on its ability to maintain thermal homeostasis. The human body can be divided arbitra...

Download PDF file
  • EP ID EP67294
  • DOI -
  • Views 127
  • Downloads 0

How To Cite

Agnieszka Piwowar (2014). Biochemical and clinical aspects of advanced oxidation protein products in kidney diseases and metabolic disturbances. Advances in Hygiene and Experimental Medicine, 68(), 179-190. https://europub.co.uk/articles/-A-67294